SECURA◊ -huidverzorgingsassortiment
Family of products
Family of products
Family of products
Indication description
Family of products
Evidence, case studies and testimonials
Family of products
Disclaimers
*Ga voor elk product uit het SECURA-huidverzorgingsassortiment na of het verkrijgbaar is in uw land of regio.
**Zoals aangetoond in een reeks casussen.
Citations
- European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. Emily Haesler (Ed.). EPUAP/NPIAP/PPPIA: 2019.
- Smith+Nephew 2020.The justification of pH buffered claim for the total body foam cleanser (TBFCI). Internal Report
- Smith+Nephew 2020. Laboratory testing of cleansing claims for the updated formulation of SECURA Total Body Foam Cleanser. Internal Report. RS\20\076
- Byers PH, Ryan PA, Regan MB, Shields A, Carta SG. Effects of Incontinence Care Cleansing Regimens on Skin Integrity. JWOCN. 1995;22(4):187-192.
- Smith+Nephew 2020.The justification of the 'saves valuable nursing time. Cost effective - 75% less cleaning time compared to soap and water' claim for the total body foam cleanser (TBFCI). Internal Report.
- Smith+Nephew 2020.SECURA Total Body Foam Cleanser and SECURA Personal Cleanser. Internal Report. PSS415.
- Hilltop Research 2007.An Evaluation of Healthcare Products on Children 0 to 36 Months of Age with Normal Skin. Internal Report. 07-128386-111.
- Smith+Nephew 2020.The justification of the 'CHG compatible' claim for the Total Body Foam Cleanser reformulation. Internal Report.
- Microbac 2012.Chlorhexidine Gluconate Compatibility Evaluation of Skin Treatment Products. Internal Report. 795-101
- Title 21 CFR Part 347 - Skin Protectant Drug Products for Over-the-Counter Human Use (Final Monograph, 06/2003)
- Global Medical Device Nomenclature Code 46206: Skin Protectant, Skin Barrier
- Skin Protectant Drug Products for Over-the-Counter Human Use: Proposed Rulemaking for Diaper Rash Drug Products, Federal Register, 06/1990
- Triple Care D Formulation (Swiss American Products).
- Global Medical Device Nomenclature Code 46206: Skin Protectant, Skin Barrier
- Study HTR 07-128386-111: An Evaluation of Healthcare Products on Children 0-36 Months of Age with Normal Skin, 11/2007.
- Health Canada. Diaper Rash Products Monograph. In. Canada: Health Products and Food Branch; 2018
- Smith+Nephew 2019.Review of MVTR data for No-Sting Skin Prep. Internal Report. RD/19/020.
- Smith+Nephew 2019.Verification testing of No-Sting Skin Prep usability report. Internal Report. U/059/R5
- Smith+Nephew 2009.Study to determine the wash-off resistance and durability of a barrier film. Internal Report. S09-58-A.
- Smith+Nephew 2019.Verification testing of No-Sting Skin Prep water resistance and longevity report. Internal Report. U/059/R2.
- Cunarro Alonso JM, Martinez Sanchez P, Puerta Morales G. Use of the non-irritating skin protector No Sting Skin Prep in a series of cases in the social health field. Paper presented at: XIII National Symposium on Pressure Ulcers and Wounds Heritage; 2010; Spain.
- Francisco JGJ, Del Mar AGM, Maria PPJ, et al. Assessment of a new non-irritating skin protector for different skin disorders. Paper presented at: XIII National Symposium on Pressure Ulcers and Wounds Heritage; 2010; Spain.
- Porras Pastor JM, Roman Manzano A, Jiminez Garcia JF, et al. Effectiveness of a non-irritating skin protectant in a series of clinical cases in primary care. Paper presented at: XIII National Symposium on Pressure Ulcers and Wounds Heritage; 2010; Spain.
- Segovia Gomez T, Bermejo Martinez M, Montero De La Pena MV, et al. Protection and treatment of perilesional skin at risk from external contaminants or forces with a non-irritating skin protector in hospital patients. Paper presented at: XIII National Symposium on Pressure Ulcers and Wounds Heritage; 2010; Spain.
- Smith+Nephew 2009.Study to determine the wash-off resistance and durability of a barrier film. Internal Report. S09-58-A.
- Smith+Nephew 2012.Chlorhexidine gluconate compatibility evaluation of skin treatment products. Internal Report. 795-101.
- Smith+Nephew 2018.Formulation - No Sting Barrier Film Spray. Internal Document.
- Smith+Nephew 2018.Formulation - Secura No Sting Barrier Film Swab. Internal Document.
- Smith+Nephew 2019.Review of No-Sting Skin Prep Drying Time. Internal Report. RD/19/026/v2.
- Smith+Nephew 2009.Assessment of the tactile characterisation of a film forming barrier. Internal Report.
- Nursing Care Moisturizing Cream Formulation (F-50).
- Evaluation of Cumulative Irritation Potential in Humans (21-day), Report # 94- 2404-72A, Hill Top Research.
- Delayed Contact Sensitization Study (Repeated Patch Method) in the Guinea Pig - Report #93C-21027-00, NAmSA
- Acute Oral Toxicity Study (FHSA) in the Rat – Report #94T-01784-00, NAmSA.